Filter
2596
Filtered Results: 2596
Text search:
Ministry
of
Health,
Public
Health
Division
Featured
Recommendations
164
New Publications
863
Language
Document type
No document type
1630
Studies & Reports
403
Guidelines
247
Manuals
148
Strategic & Response Plan
96
Training Material
27
Fact sheets
20
Situation Updates
15
Resource Platforms
5
Brochures
4
Infographics
1
Countries / Regions
India
194
Kenya
150
Nepal
123
Uganda
82
Global
80
Bangladesh
78
Myanmar / Burma
76
Liberia
70
Rwanda
69
Nigeria
64
Ghana
54
Western and Central Europe
48
Congo, Democratic Republic of
47
Namibia
46
Sierra Leone
44
Ethiopia
43
Africa
37
Malawi
36
Senegal
34
Tanzania
30
Zambia
30
Latin America and the Carribbean
28
Ukraine
26
Lesotho
23
Syria
22
Eastern Europe
20
Cameroon
18
Indonesia
18
South–East Asia Region
17
South Africa
17
Botswana
17
Asia
16
Zimbabwe
15
South Sudan
15
Guinea
14
Mozambique
14
Haiti
13
Benin
12
Burkina Faso
11
Pakistan
11
Afghanistan
9
Philippines
9
Cambodia
9
Western Pacific Region
9
Eastern Europe and Central Asia
9
Vietnam
9
Yemen
9
Central African Republic
9
Laos
8
West and Central Africa
8
Middle East and North Africa
8
East and Southern Africa
8
Mali
8
Thailand
7
Jordan
7
Sri Lanka
7
Eswatini/ Swaziland
7
Tajikistan
6
Colombia
6
Togo
6
Lebanon
6
Somalia
6
Madagascar
6
Venezuela
5
Moldova
5
Kyrgyzstan
4
Brazil
4
Sudan
4
Chad
4
Bhutan
4
Iraq
4
North Macedonia
3
Turkey
3
Chile
3
Iran
3
Albania
3
Niger
3
Peru
3
Morocco
3
Germany
3
Paraguay
3
Turkmenistan
3
Bosnia and Herzegovina
3
Côte d’Ivoire / Ivory Coast
3
Angola
3
China
2
Singapore
2
Burundi
2
Armenia
2
Croatia
2
Jamaica
2
Mauritius
2
Portugal
2
Spain
2
Russia
2
Greece
2
Timor Leste/ East Timor
1
Mexico
1
Serbia
1
Kazakhstan
1
Canada
1
Fiji
1
Malaysia
1
Vanuatu
1
Mongolia
1
Qatar
1
Bulgaria
1
Mauritania
1
Guinea-Bissau
1
Hungary
1
Saudi Arabia
1
North America
1
Japan
1
France
1
Maldives
1
Tunisia
1
United Kingdom
1
Azerbaijan
1
Belarus
1
Israel
1
Southern Africa
1
Bolivia
1
Argentina
1
Papua New Guinea
1
Romania
1
Slovakia
1
Palestine
1
Georgia
1
Poland
1
Libya
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1400
Key Resources
136
Public Health
119
Clinical Guidelines
117
Women & Child Health
116
Capacity Building
31
Pharmacy & Technologies
15
Toolboxes
Mental Health
124
COVID-19
119
HIV
117
TB
107
Disability
104
Planetary Health
81
AMR
79
Rapid Response
69
Caregiver
58
Ebola & Marburg
57
Conflict
57
NTDs
56
Refugee
45
Pharmacy
40
Global Health Education
39
Natural Hazards
30
NCDs
28
Health Financing Toolbox
23
Cholera
13
Polio
11
Specific Hazards
9
Social Ethics
9
Zika
9
Malaria
3
Typhoon
2
This document aims to support those working in primary care to strengthen IPC, informed by existing WHO IPC guidance and implementation resources. Many of the existing WHO IPC guidance and implementation resources initially developed for acute health care facilities have a potential utility for IPC ...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
The annual Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment and the World Health Organization (WHO) Core Assessment Group on Pesticide Residues (JMPR) was held in Rome, Italy, from 13 to 22 September...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and the achievement of Millennium Development Goals such as a reduction in infant and under-five morta...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi...
The preparedness strengthening team deployed to Ghana focused on specific objectives in order to assist the country in becoming as operationally prepared as possible to detect, investigate and report potential EVD cases effectively and safely and to mount an effective response to prevent a larger o...
At the end of 2023, WHO convened our first-ever annual WHO Stakeholder Review Conference for Prevention and Response to Sexual Misconduct. Aimed at joint learning and frank discussion on challenges faced in the achieving zero tolerance for all forms of sexual misconduct by aid workers, the Conferenc...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool
for assessing and managing p...
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge,...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The 2023 Country Presence Report provides an overview of what WHO does in countries to advance towards the SDGs and implement GPW13, how we do it, with whom we work, and what is needed to overcome challenges for achieving results and impact in countries.
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
Global Report on assistive technology
recommended
The report notes that the number of people in need of one or more assistive products is likely to rise to 3.5 billion by 2050, due to populations ageing and the prevalence of noncommunicable diseases rising across the world. The report also highlights the vast gap in access between low- and high-inc...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
